Stonegate Capital Partners Updates Coverage on GoHealth Inc. (GOCO) 2025 Q3
GoHealth (NASDAQ: GOCO) reported a challenging 3Q25 with net revenues of $34.2M, down ~71.0% y/y as the company intentionally pulled back Medicare Advantage volume and experienced reduced non-agency activity.
Other revenue grew as GoHealth Protect scaled. Results were depressed by significant non-cash impairment charges, while management emphasized liquidity preservation, platform efficiency, retention-first actions, and disciplined execution through the 2025 AEP. Liquidity at quarter end was $32.1M and strategic flexibility improved via a superpriority term loan and covenant relief.
GoHealth (NASDAQ: GOCO) ha riportato una sfida nel 3Q25 con ricavi netti di $34.2M, in calo di circa 71,0% su base annua poiché l'azienda ha intenzionalmente ridotto il volume di Medicare Advantage e ha registrato attività non legate all'agenzia ridotte.
Altri ricavi sono aumentati mentre GoHealth Protect si è espanso. I risultati sono stati penalizzati da significative svalutazioni non monetarie, mentre la direzione ha sottolineato la preservazione della liquidità, l'efficienza della piattaforma, azioni orientate alla retention e un'esecuzione disciplinata durante l'AEP 2025. La liquidità alla chiusura del trimestre era di $32.1M e la flessibilità strategica è migliorata grazie a un prestito a termine di superpriorità e a un allentamento delle covenant.
GoHealth (NASDAQ: GOCO) reportó un trimestre desafiante 3Q25 con ingresos netos de $34.2M, en descenso aproximadamente de 71,0% interanual, ya que la empresa redujo intencionalmente el volumen de Medicare Advantage y experimentó menor actividad no relacionada con agencias.
Otros ingresos crecieron mientras GoHealth Protect se expandía. Los resultados estuvieron deprimidos por significativas cargas de deterioro no monetarias, mientras la dirección enfatizó la preservación de la liquidez, la eficiencia de la plataforma, acciones centradas en la retención y una ejecución disciplinada hasta el AEP 2025. La liquidez al cierre del trimestre fue de $32.1M y la flexibilidad estratégica mejoró gracias a un préstamo de prioridad superior y alivio de covenants.
GoHealth (NASDAQ: GOCO) 3분기 3Q25를 34.2백만 달러의 순매출로 발표했으며, 회사가 의도적으로 Medicare Advantage 규모를 축소했고 비에이전시(non-agency) 활동이 감소하여 전년 대비 약 71.0% 하락했습니다.
다른 매출은 GoHealth Protect가 확장되면서 증가했습니다. 실질 비현금 손상충당으로 결과가 하방 압력을 받았고, 경영진은 2025년 AEP를 통해 유동성 보존, 플랫폼 효율성, 유지 중심의 조치 및 규율 있는 실행을 강조했습니다. 분기말 유동성은 $32.1M였고, 슈퍼우선권(우선순위가 높은) 대출과 covenant 면제로 전략적 유연성은 개선되었습니다.
GoHealth (NASDAQ: GOCO) a enregistré un trimestre difficile 3Q25 avec des revenus nets de $34.2M, en baisse d"environ 71,0% en glissement annuel alors que l"entreprise a intentionnellement réduit le volume de Medicare Advantage et a connu une activité non liée aux agences réduite.
D'autres revenus ont augmenté pendant que GoHealth Protect se développait. Les résultats ont été freinés par d"importantes charges de dépréciation non monétaires, tandis que la direction a mis l'accent sur la préservation de la liquidité, l'efficacité de la plateforme, des actions axées sur la rétention et une exécution disciplinée jusqu'à l'AEP 2025. La liquidité à la fin du trimestre était de $32.1M et la flexibilité stratégique s'est améliorée grâce à un prêt à termes de superpriorité et à un allègement des covenants.
GoHealth (NASDAQ: GOCO) meldete ein herausforderndes 3Q25 mit Nettoumsätzen von $34.2M, rückläufig um ca. 71,0% YoY, da das Unternehmen absichtlich Medicare Advantage-Volumen reduziertes und reduzierte nicht-agenturbezogene Aktivitäten erlebte.
Sonstige Umsätze wuchsen, da GoHealth Protect skaliert wurde. Die Ergebnisse wurden durch signifikante, nicht zahlungswirksame Wertminderungen gedrückt, während das Management die Liquiditätserhaltung, Plattform-Effizienz, retention-orientierte Maßnahmen und eine disziplinierte Umsetzung bis zum AEP 2025 betonte. Die Liquidität zum Quartalsende betrug $32.1M und die strategische Flexibilität wurde durch einen Term Loan mit Superpriorität und Covenant-Erleichterungen verbessert.
GoHealth (NASDAQ: GOCO) أبلغت عن 3Q25 صعب مع إيرادات صافية قدرها $34.2M, بانخفاض يقارب 71.0% على أساس سنوي حيث قامت الشركة عمداً بخفض حجم Medicare Advantage وتجربة نشاط غير تابع للوكالات منخفض.
زادت إيرادات أخرى مع توسيع GoHealth Protect. كانت النتائج مثقلة بعبء انخفاض غير نقدي كبير، في حين أكدت الإدارة على الحفاظ على السيولة وكفاءة المنصة والإجراءات المتمركزة حول الاحتفاظ وتنفيذ منضبط حتى AEP 2025. بلغت السيولة عند نهاية الربع $32.1M وتحسنت المرونة الاستراتيجية بفضل قرض طويل الأجل ذو أولوية عالية وتخفيف الالتزامات العقدية.
- Net revenues included growth in GoHealth Protect offerings
- Quarter-end cash of $32.1M
- Strategic flexibility via superpriority term loan and covenant relief
- Net revenues declined to $34.2M (≈71% y/y)
- Meaningful declines in Medicare agency and non-agency revenues
- Significant non-cash impairment charges pressured margins
Dallas, Texas--(Newsfile Corp. - November 17, 2025) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners updates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. reported a difficult 3Q25 as the Company continued to navigate a materially different Medicare Advantage environment. Net revenues declined to
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- In 3Q25, net revenues were
$34.2M , down ~71.0% y/y, reflecting an intentional Medicare Advantage pullback and mix shift. - As of quarter end, management highlighted a retention first focus leadership in Special Needs Plans and preserved agent tech and retention ops.
- Liquidity was
$32.1M in cash and strategic flexibility improved with a superpriority term loan and covenant relief.
Click image above to view full announcement.
About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.
Contacts:
Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com
Source: Stonegate, Inc.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274792
FAQ
What were GoHealth (GOCO) revenues in 3Q25 and how big was the decline?
How much cash did GoHealth (GOCO) report at the end of 3Q25?
Why did GoHealth (GOCO) revenues fall sharply in 3Q25?
Did GoHealth (GOCO) take any financing actions in 3Q25 to improve flexibility?
What impact did impairments have on GoHealth (GOCO) 3Q25 results?
Is GoHealth (GOCO) growing other revenue streams in 2025?
